Phase Forward to Present at the Piper Jaffray 7th Annual Technology Conference

Business Wire, May 3, 2005

WALTHAM, Mass. -- Phase Forward Incorporated (NASDAQ: PFWD), a leading provider of data management solutions for clinical trials and drug safety, announced today that it will participate in the Piper Jaffray 7th Annual Technology Conference to be held in New York, May 11 to 13, 2005. Phase Forward President and Chief Executive Officer, Bob Weiler, and Senior Vice President and Chief Financial Officer, Rodger Weismann, will speak at the conference on Friday, May 13, 2005, at 8:50 AM (EDT). The presentation will be available live via audio web cast at the company's web site, www.phaseforward.com.

About Phase Forward

Phase Forward is a leading provider of integrated data management solutions for clinical trials and drug safety. The company helps pharmaceutical, biotechnology, and medical device companies bring needed drugs and therapies to market faster and more safely. Phase Forward offers proven solutions in electronic data capture (EDC), clinical data management (CDM), and adverse event reporting (AER). Phase Forward products and services have been utilized in over 10,000 clinical trials involving more than 1,000,000 clinical trial study participants at over 220 organizations worldwide including: AstraZeneca, Biogen Idec, Boston Scientific, Dana-Farber Cancer Institute, Eli Lilly, GlaxoSmithKline, Guidant, Procter & Gamble, Quintiles, Sanofi-Aventis, Schering-Plough Research Institute, and Serono. Additional information about Phase Forward is available at www.phaseforward.com.